Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aurobindo Pharma Q4 net profit, revenue rise on Europe growth; US sales decline
Shares of Aurobindo Pharma Ltd ended at ₹1,546.45, up by ₹28.55, or 1.88%, on the BSE.
Aurobindo Pharma Ltd up for third consecutive session
Aurobindo Pharma Ltd is quoting at Rs 1541.4, up 1.57% on the day as on 12:49 IST on the NSE. The stock is up 29.73% in last one year as compared to a 3.98% slide in NIFTY and a 15.38% slide in the Nifty Pharma index.
Q4 Results Today: Aurobindo Pharma, GAIL, LIC, ITC, Nykaa, Honasa Consumer — Check Estimates
According to Bloomberg estimates, ITC is expected to post largely flat profit growth as higher tobacco leaf costs and pressure on cigarette volumes weigh on margins.
Q4 Results LIVE Updates: Sanghvi Movers shares surge over 12%; Jubilant Foodworks down 7%
Q4 Results LIVE Updates: ITC, Aurobindo Pharma, LIC, LG Electronics, Ashoka Buildcon, Bikaji Foods, Datamatics, Engineers India, GMM Pfaudler, Happy Forgings, Honasa Consumer, Ixigo, Nykaa, Page Industries, Ramco Cements, Max Healthcare, Prestige Estates, MTNL, Sun TV, Quick Heal, RCF, WeWork, VA Tech Wabag, are among the companies reporting their earnings today. The street will also react to numbers reported by Whirlpool, Apollo Hospitals, Sammaan Capital, JK Lakshmi Cement, Lenskart, Ola Electric and others. Watch this space for all the LIVE earnings updates.
Five Stocks To Buy: Aurobindo Pharma, Tata Communications, Graphite India And More | May 18, 2026
Top picks include pharma majors Aurobindo Pharma and OneSource Specialty Pharma, agrochemical player Sumitomo Chemical India, telecom giant Tata Communications, and industrial manufacturing firm Graphite India.
Aurobindo Pharma Ltd soars 1.15%
Aurobindo Pharma Ltd is quoting at Rs 1514.7, up 1.15% on the day as on 12:49 IST on the NSE. The stock is up 24.47% in last one year as compared to a 5.39% drop in NIFTY and a 13.06% drop in the Nifty Pharma index.
Stock picks: Analyst prefer Aurobindo Pharma, Sona BLW, Tata Steel
Stock picks: Ajit Mishra of Religare Broking recommends buying Aurobindo Pharma, Tata Steel & Sona BLW; here's why
Aurobindo Pharma to launch ₹800 crore buyback at ₹1,475 per share from April 23
Shares of Aurobindo Pharma Ltd ended at ₹1,387.05, up by ₹19.35, or 1.41%, on the BSE.
CLSA says Nifty has given a new signal on the charts; check potential returns and top midcap 'buys'
Laurence Balanco of CLSA has shared five midcap ideas: BSE, MCX, Apollo Tubes, Dixon Technologies and Aurobindo Pharma.
Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out for
Four companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo’s record date due soon. Buybacks involve companies repurchasing shares to boost value, use surplus cash, or strengthen ownership. Meanwhile, new rules under the Finance Bill 2026 impose a 12% surcharge on buyback-related capital gains for promoters, while other investors remain taxed as per existing norms.
Aurobindo Pharma share buyback, Muthoot Fin dividend, 2 other corporate actions next week
Aurobindo Pharma’s share buyback and Muthoot Finance’s dividend announcement headline a set of four key corporate actions lined up for the coming week.
AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore
The land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva Group, Aurobindo Pharma and RMZ. The company is looking to sell it as part of a broader land monetisation strategy.